Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study

  • Mark H. Einstein
  • , Myron J. Levin
  • , Archana Chatterjee
  • , Nahida Chakhtoura
  • , Peter Takacs
  • , Grégory Catteau
  • , Francis J. Dessy
  • , Philippe Moris
  • , Lan Lin
  • , Frank Struyf
  • , Gary Dubin
  • , Mark Blatter
  • , Christopher V. Chambers
  • , Marina Fernandez
  • , Bradley Fox
  • , David L. Fried
  • , Sidney A. Funk
  • , Cheryl A. Hansen
  • , James A. Hedrick
  • , Bethany Hoffman
    • Terry D. Klein, Jacob Lalezari, Michael J. Noss, James H. Silverblatt, Rhoda S. Sperling, Karen G. Swenson, Troy Thompson, Mark Turner, Michael W. Warren, Robert Yoachim

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: Follow-up through Month 48 in a Phase III randomized study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology